Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 3M COMMM · Entity 1275 | Director | May 12, 2026 | May 13, 2026 |
| DOW INC.DOW · Entity 3233 | Director · Chair and CEO | February 12, 2026 | May 01, 2026 |
| TCF FINANCIAL CORPCHFC · Entity 106138 | Director | June 21, 2019 | June 24, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
3M CO
Report date May 12, 2026 · Filed May 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Corporation | 7,868.463 |
Reported balance
After 2026-05-12 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-05-12 · Grant · Acquired 1,360.402 · Balance 7,868.463 F1: Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors. F2: This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account. |
| Common StockSEC Table I · non-derivative | Direct | 11,412.005 |
Reported balance
Holding disclosure · report date 2026-05-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,412.005 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 200 |
Reported balance
Holding disclosure · report date 2026-05-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 200 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors.
F2: This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account.
DOW INC.
Report date February 12, 2026 · Filed May 01, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 190,117 |
Reported balance
After 2026-02-12 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-02-12 · Grant · Acquired 68,230 · Balance 190,117 F1: Restricted stock units to be delivered in one installment on or about February 12, 2029, subject to continued employment. F2: Total includes previously reported restricted stock units. F3: This amount represents the correct amount of securities beneficially owned by the Reporting Person following the reported transaction. The Form 4 filed by the Reporting Person on February 17, 2026 erroneously reported a transaction that did not occur. This amendment is being filed solely to remove the erroneously reported transaction in its entirety and corrects the total amount reflected in this column. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units to be delivered in one installment on or about February 12, 2029, subject to continued employment.
F2: Total includes previously reported restricted stock units.
F3: This amount represents the correct amount of securities beneficially owned by the Reporting Person following the reported transaction. The Form 4 filed by the Reporting Person on February 17, 2026 erroneously reported a transaction that did not occur. This amendment is being filed solely to remove the erroneously reported transaction in its entirety and corrects the total amount reflected in this column.
TCF FINANCIAL CORP
Report date June 21, 2019 · Filed June 24, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,201.86 |
Reported balance
After 2019-06-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-21 · Grant · Acquired 4,710.089 · Balance 11,201.86 F1: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. |
| Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,298.403 |
Reported balance
After 2019-06-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-06-21 · Grant · Acquired 96.543 · Balance 11,298.403 F2: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company.
F2: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DOW CHEMICAL CO /DE/
Report date August 31, 2017 · Filed September 05, 2017
Section 16 reporting ended · disclosed 2017-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 1
1 source rowRow 1 · 2017-08-31 · Disposition to issuer · Disposed 258,154.949 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2: Includes 18,710 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 25,810 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 19,410 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment. |
| CommonSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2017-08-31 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-08-31 · Disposition to issuer · Disposed 1,634.041 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. |
| CommonSEC Table I · non-derivative | IndirectBy 401(k) Plan ESOP | 0 |
Reported balance
After 2017-08-31 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2017-08-31 · Disposition to issuer · Disposed 4,384.6034 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.00 · Expires 2022-02-10 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-08-31 · Disposition to issuer · Disposed 61,830 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.19 · Expires 2027-02-10 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-31 · Disposition to issuer · Disposed 98,690 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.38 · Expires 2021-02-11 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-31 · Disposition to issuer · Disposed 118,090 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.01 · Expires 2026-02-12 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-08-31 · Disposition to issuer · Disposed 130,140 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.44 · Expires 2025-02-13 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-08-31 · Disposition to issuer · Disposed 95,610 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.71 · Expires 2024-02-14 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-08-31 · Disposition to issuer · Disposed 96,220 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2023-02-15 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-08-31 · Disposition to issuer · Disposed 210,880 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
F2: Includes 18,710 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 25,810 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 19,410 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.
F3: This option was fully vested and exercisable at the time of the Merger.
F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option.
F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.
F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.
F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.
DuPont de Nemours, Inc.
Report date April 01, 2019 · Filed April 04, 2019
Section 16 reporting ended · disclosed 2019-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 140,193 |
Reported balance
After 2019-04-01 transaction · row 1
1 source rowRow 1 · 2019-04-01 · Grant · Acquired 55,650 · Balance 140,193 F1: Performance share units not previously reportable vested upon determination by the DowDuPont Inc. Compensation Committee on April 1, 2019, that the synergy capture maximum performance criteria had been met. Additional performance-based targets remain. Performance share units will be settled in one installment on or about September 1, 2019, subject to continued employment. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 1,909.623 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,909.623 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan ESOP | 5,166.068 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,166.068 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 217,287.949 |
Reported balance
Holding disclosure · report date 2019-04-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 217,287.949 |
Filing footnotes · ownership attribution and instrument terms
F1: Performance share units not previously reportable vested upon determination by the DowDuPont Inc. Compensation Committee on April 1, 2019, that the synergy capture maximum performance criteria had been met. Additional performance-based targets remain. Performance share units will be settled in one installment on or about September 1, 2019, subject to continued employment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2017 Filed Feb 10, 2017 21:52 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 48,390 | $59.94 | $2,900,254.65 |
DisclosureSEC source: 0001225208-17-002785 · doc4.xml · nonDerivative · entry 6 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,349.949 Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 21:52 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 14,671 | $59.94 | $879,306.39 |
DisclosureSEC source: 0001225208-17-002785 · doc4.xml · nonDerivative · entry 5 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,739.949 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 21:52 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 3,571 | $59.94 | $214,027.89 |
DisclosureSEC source: 0001225208-17-002785 · doc4.xml · nonDerivative · entry 4 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,410.949 Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 21:52 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 1,908 | $59.94 | $114,355.98 |
DisclosureSEC source: 0001225208-17-002785 · doc4.xml · nonDerivative · entry 3 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,981.949 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 21:52 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionCommon | 7,700 | $27.79 | $213,983.00 |
DisclosureSEC source: 0001225208-17-002785 · doc4.xml · nonDerivative · entry 2 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,889.949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 21:52 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionCommon | 85,300 | $34.00 | $2,900,200.00 |
DisclosureSEC source: 0001225208-17-002785 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,189.949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 17:06 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | PurchaseCommon Stock | 1,500 | $48.57 | $72,853.50 |
DisclosureSEC source: 0000905729-17-000040 · fitterling4_013117.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,044.358 Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:11 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | GiftCommon | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-041850 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,889.949 Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 16:31 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | Exercise / conversionStock Units · Derivative | 10,198.337 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-16-000720 · fitterling4_092716.xml · derivative · entry 2 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,198.337 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Stock units issued under the Chemical Financial Corporation Directors' Deferred Stock Plan were converted into shares of common stock on a one-for-one basis in a lump sum in connection with the merger of Talmer Bancorp, Inc. with and into Chemical Financial Corporation. The reporting person will receive cash in lieu of any fractional shares that would otherwise have resulted from such conversion. F2 · derivative.exercise_date: Stock units issued under the Chemical Financial Corporation Directors' Deferred Stock Plan were converted into shares of common stock on a one-for-one basis in a lump sum in connection with the merger of Talmer Bancorp, Inc. with and into Chemical Financial Corporation. The reporting person will receive cash in lieu of any fractional shares that would otherwise have resulted from such conversion. F2 · derivative.expiration_date: Stock units issued under the Chemical Financial Corporation Directors' Deferred Stock Plan were converted into shares of common stock on a one-for-one basis in a lump sum in connection with the merger of Talmer Bancorp, Inc. with and into Chemical Financial Corporation. The reporting person will receive cash in lieu of any fractional shares that would otherwise have resulted from such conversion. Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 16:31 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | Exercise / conversionCommon Stock | 10,198 | $0.00 | $0.00 |
DisclosureSEC source: 0000905729-16-000720 · fitterling4_092716.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,544.358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 687.959 shares acquired since 6/2/2014 in exempt dividend reinvestment transactions. Read SEC document |
| September 16, 2016 Filed Sep 20, 2016 13:53 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 214.15 | $44.30 | $9,486.85 |
DisclosureSEC source: 0000905729-16-000714 · fitterling4_092016.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,198.337 Underlying: Common Stock · 214.15 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.